{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:40:12Z","timestamp":1772160012600,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsmedizin Greifswald"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Currently total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) are used in clinical practice to estimate future cardiovascular risk. We assessed whether other lipoprotein subclasses also contribute to cause-specific and all-cause mortality in the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Two independent cohorts of the Study of Health in Pomerania (SHIP-START and SHIP-TREND) were used. Participants were selected from population registration offices. The primary outcomes were all-cause, cardiovascular and cancer mortality. TC, total triglycerides (TG), phospholipids as well as the fractional concentrations of cholesterol, TG, phospholipids, and apolipoproteins of all lipoprotein subclasses were measured using nuclear magnetic resonance spectroscopy. Cox proportional hazard regression models were applied to assess the association between lipoprotein subclasses and mortality. Additionally, cause-specific hazards for cardiovascular disease (CVD) and cancer mortality were modelled considering competing events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Data from 3,579 SHIP-START and 4,267 SHIP-TREND individuals were included. During follow-up, 946 (26.4%) SHIP-START and 387 (9.1%) SHIP-TREND participants died. In both cohorts, total LDL-TG and LDL1-TG to LDL6-TG but not total TG were positively or U-shaped related with all-cause mortality. In SHIP-START, total TG, VLDL-TG, IDL-TG and LDL-TG (including subclasses) were associated with CVD mortality. HDL4-C as well as small and dense LDL-C (e.g. LDL6-C) represented risk factors for mortality with mutually enhancing effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings suggest that lipoprotein subclasses, especially LDL-TGs or HDL4-C\/LDL6-C, provide information beyond the established TC and LDL-C levels and therefore might be of use for an early identification of subjects at risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-025-02779-0","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:58:40Z","timestamp":1763135920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Associations of lipoprotein subclasses with all-cause and cardiovascular mortality: results of two independent cohorts with a 20 year follow-up"],"prefix":"10.1186","volume":"24","author":[{"given":"Florian","family":"Fierfas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bahls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Kristin","family":"Henning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Petersmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Budde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"V\u00f6lzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Nauck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Hannemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nele","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"2779_CR1","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1161\/CIRCULATIONAHA.118.034273","volume":"138","author":"SM Abdullah","year":"2018","unstructured":"Abdullah SM, Defina LF, Leonard D, Barlow CE, Radford NB, Willis BL, et al. Long-term association of low-density lipoprotein cholesterol with cardiovascular mortality in individuals at low 10-year risk of atherosclerotic cardiovascular disease. Circulation. 2018;138:2315\u201325.","journal-title":"Circulation"},{"key":"2779_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","volume":"62","author":"T Gordon","year":"1977","unstructured":"Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med. 1977;62:707\u201314.","journal-title":"Am J Med"},{"key":"2779_CR3","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1001\/jama.2018.2525","volume":"319","author":"EP Navarese","year":"2018","unstructured":"Navarese EP, Robinson JG, Kowalewski M, Kolodziejczak M, Andreotti F, Bliden K, et al. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis. JAMA. 2018;319:1566\u201379.","journal-title":"JAMA"},{"key":"2779_CR4","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.2215\/CJN.03650411","volume":"6","author":"N Noori","year":"2011","unstructured":"Noori N, Caulfield MP, Salameh WA, Reitz RE, Nicholas SB, Molnar MZ, et al. Novel lipoprotein subfraction and size measurements in prediction of mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2011;6:2861\u201370.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2779_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/eurheartj\/ehu055","volume":"36","author":"TB Grammer","year":"2015","unstructured":"Grammer TB, Kleber ME, Marz W, Silbernagel G, Siekmeier R, Wieland H, et al. Low-density lipoprotein particle diameter and mortality: the Ludwigshafen risk and cardiovascular health study. Eur Heart J. 2015;36:31\u20138.","journal-title":"Eur Heart J"},{"key":"2779_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023690","volume":"11","author":"S Rong","year":"2022","unstructured":"Rong S, Li B, Chen L, Sun Y, Du Y, Liu B, et al. Association of low-density lipoprotein cholesterol levels with more than 20-year risk of cardiovascular and all-cause mortality in the general population. J Am Heart Assoc. 2022;11:e023690.","journal-title":"J Am Heart Assoc"},{"key":"2779_CR7","unstructured":"Feingold KR. In: Feingold, et al. editors. Utility of advanced lipoprotein testing in clinical practice. South Dartmouth (MA); 2000. Endotext, K.R."},{"key":"2779_CR8","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1001\/jama.1988.03410130125037","volume":"260","author":"MA Austin","year":"1988","unstructured":"Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917\u201321.","journal-title":"JAMA"},{"key":"2779_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1273042","volume":"2017","author":"EA Ivanova","year":"2017","unstructured":"Ivanova EA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN. Small dense low-density lipoprotein as biomarker for atherosclerotic diseases. Oxid Med Cell Longev. 2017;2017:1273042.","journal-title":"Oxid Med Cell Longev"},{"key":"2779_CR10","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1161\/01.CIR.0000146898.06923.80","volume":"110","author":"W Marz","year":"2004","unstructured":"Marz W, Scharnagl H, Winkler K, Tiran A, Nauck M, Boehm BO, et al. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen risk and cardiovascular health study. Circulation. 2004;110:3068\u201374.","journal-title":"Circulation"},{"key":"2779_CR11","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1093\/eurheartj\/ehx118","volume":"38","author":"S Zewinger","year":"2017","unstructured":"Zewinger S, Kleber ME, Rohrer L, Lehmann M, Triem S, Jennings RT, et al. Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease. Eur Heart J. 2017;38:1597\u2013607.","journal-title":"Eur Heart J"},{"key":"2779_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.immuni.2013.02.009","volume":"38","author":"T Speer","year":"2013","unstructured":"Speer T, Rohrer L, Blyszczuk P, Shroff R, Kuschnerus K, Krankel N, et al. Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2. Immunity. 2013;38:754\u201368.","journal-title":"Immunity"},{"key":"2779_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jacc.2018.10.059","volume":"73","author":"WG Hunter","year":"2019","unstructured":"Hunter WG, McGarrah RW 3rd, Kelly JP, Khouri MG, Craig DM, Haynes C, et al. High-Density lipoprotein particle subfractions in heart failure with preserved or reduced ejection fraction. J Am Coll Cardiol. 2019;73:177\u201386.","journal-title":"J Am Coll Cardiol"},{"key":"2779_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/eurheartj\/ehu264","volume":"36","author":"SS Martin","year":"2015","unstructured":"Martin SS, Khokhar AA, May HT, Kulkarni KR, Blaha MJ, Joshi PH, et al. HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborative. Eur Heart J. 2015;36:22\u201330.","journal-title":"Eur Heart J"},{"key":"2779_CR15","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.2337\/diabetes.51.6.1949","volume":"51","author":"HM Colhoun","year":"2002","unstructured":"Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes. 2002;51:1949\u201356.","journal-title":"Diabetes"},{"key":"2779_CR16","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/01.ATV.18.7.1046","volume":"18","author":"DS Freedman","year":"1998","unstructured":"Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol. 1998;18:1046\u201353.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2779_CR17","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1161\/01.ATV.17.6.1098","volume":"17","author":"B Lamarche","year":"1997","unstructured":"Lamarche B, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despres JP. Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Quebec cardiovascular study. Arterioscler Thromb Vasc Biol. 1997;17:1098\u2013105.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2779_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/ije\/dyp394","volume":"40","author":"H V\u00f6lzke","year":"2011","unstructured":"V\u00f6lzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40:294\u2013307.","journal-title":"Int J Epidemiol"},{"key":"2779_CR19","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1177\/2047487319894114","volume":"27","author":"M Feng","year":"2020","unstructured":"Feng M, Darabi M, Tubeuf E, Canicio A, Lhomme M, Frisdal E, et al. Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease. Eur J Prev Cardiol. 2020;27:1606\u201316.","journal-title":"Eur J Prev Cardiol"},{"key":"2779_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/709756","volume":"2014","author":"D Ding","year":"2014","unstructured":"Ding D, Li X, Qiu J, Li R, Zhang Y, Su D, et al. Serum lipids, apolipoproteins, and mortality among coronary artery disease patients. BioMed Res Int. 2014;2014:709756.","journal-title":"BioMed Res Int"},{"key":"2779_CR21","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","volume":"38","author":"CM Madsen","year":"2017","unstructured":"Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J. 2017;38:2478\u201386.","journal-title":"Eur Heart J"},{"key":"2779_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.783618","volume":"9","author":"W Wu","year":"2022","unstructured":"Wu W, Xiao Z, Liang X, Zhao Q, Luo J, Ding D. Low and high-density lipoprotein cholesterol and 10-year mortality in community-dwelling older adults: the Shanghai aging study. Front Med. 2022;9:783618.","journal-title":"Front Med"},{"key":"2779_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-12-159","volume":"12","author":"J Liu","year":"2013","unstructured":"Liu J, Zeng FF, Liu ZM, Zhang CX, Ling WH, Chen YM. Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies. Lipids Health Dis. 2013;12:159.","journal-title":"Lipids Health Dis"},{"key":"2779_CR24","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/01.CIR.55.5.767","volume":"55","author":"WP Castelli","year":"1977","unstructured":"Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, et al. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation. 1977;55:767\u201372.","journal-title":"Circulation"},{"key":"2779_CR25","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/eurheartj\/ehi373","volume":"26","author":"C Ballantyne","year":"2005","unstructured":"Ballantyne C, Arroll B, Shepherd J. Lipids and CVD management: towards a global consensus. Eur Heart J. 2005;26:2224\u201331.","journal-title":"Eur Heart J"},{"key":"2779_CR26","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/eurheartj\/ehac822","volume":"44","author":"BN Wadstrom","year":"2023","unstructured":"Wadstrom BN, Pedersen KM, Wulff AB, Nordestgaard BG. Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality. Eur Heart J. 2023;44:1432\u201345.","journal-title":"Eur Heart J"},{"key":"2779_CR27","doi-asserted-by":"crossref","unstructured":"Nowak MM, Niemczyk M, Florczyk M, Kurzyna M. and Paczek L. Effect of Statins on All-Cause mortality in adults: A systematic review and Meta-Analysis of propensity Score-Matched studies. J Clin Med. 2022;11:5643.","DOI":"10.3390\/jcm11195643"},{"key":"2779_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1298-5","volume":"17","author":"I Tramacere","year":"2019","unstructured":"Tramacere I, Boncoraglio GB, Banzi R, Del Giovane C, Kwag KH, Squizzato A, et al. Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis. BMC Med. 2019;17:67.","journal-title":"BMC Med"},{"key":"2779_CR29","unstructured":"Linton MF, Yancey PG, Davies SS, Jerome WG, Linton EF, Song WL, et al. In: Feingold, et al. editors. The role of lipids and lipoproteins in atherosclerosis. South Dartmouth (MA); 2000. Endotext, K.R."},{"key":"2779_CR30","first-page":"8","volume":"79","author":"DJ Gordon","year":"1989","unstructured":"Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four Prospective Am Studies Circulation. 1989;79:8\u201315.","journal-title":"Four Prospective Am Studies Circulation"},{"key":"2779_CR31","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1177\/2047487320914756","volume":"27","author":"GC Zhong","year":"2020","unstructured":"Zhong GC, Huang SQ, Peng Y, Wan L, Wu YQ, Hu TY, et al. HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a j-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies. Eur J Prev Cardiol. 2020;27:1187\u2013203.","journal-title":"Eur J Prev Cardiol"},{"key":"2779_CR32","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1001\/jamacardio.2022.0912","volume":"7","author":"C Liu","year":"2022","unstructured":"Liu C, Dhindsa D, Almuwaqqat Z, Ko YA, Mehta A, Alkhoder AA, et al. Association between high-density lipoprotein cholesterol levels and adverse cardiovascular outcomes in high-risk populations. JAMA Cardiol. 2022;7:672\u201380.","journal-title":"JAMA Cardiol"},{"key":"2779_CR33","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.2215\/CJN.00730116","volume":"11","author":"B Bowe","year":"2016","unstructured":"Bowe B, Xie Y, Xian H, Balasubramanian S, Zayed MA, Al-Aly Z. High density lipoprotein cholesterol and the risk of All-cause mortality among U.S. veterans. Clin J Am Soc Nephrol. 2016;11:1784\u201393.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2779_CR34","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/ije\/dyaa243","volume":"50","author":"SW Yi","year":"2021","unstructured":"Yi SW, Park SJ, Yi JJ, Ohrr H, Kim H. High-density lipoprotein cholesterol and all-cause mortality by sex and age: a prospective cohort study among 15.8 million adults. Int J Epidemiol. 2021;50:902\u201313.","journal-title":"Int J Epidemiol"},{"key":"2779_CR35","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1161\/ATVBAHA.112.248617","volume":"32","author":"CY Huang","year":"2012","unstructured":"Huang CY, Lin FY, Shih CM, Au HK, Chang YJ, Nakagami H, et al. Moderate to high concentrations of high-density lipoprotein from healthy subjects paradoxically impair human endothelial progenitor cells and related angiogenesis by activating Rho-associated kinase pathways. Arterioscler Thromb Vasc Biol. 2012;32:2405\u201317.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2779_CR36","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","volume":"357","author":"PJ Barter","year":"2007","unstructured":"Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007;357:2109\u201322.","journal-title":"N Engl J Med"},{"key":"2779_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jacc.2022.10.019","volume":"81","author":"M Balling","year":"2023","unstructured":"Balling M, Afzal S, Davey Smith G, Varbo A, Langsted A, Kamstrup PR, et al. Elevated LDL triglycerides and atherosclerotic risk. J Am Coll Cardiol. 2023;81:136\u201352.","journal-title":"J Am Coll Cardiol"},{"key":"2779_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4266","volume":"371","author":"CDL Johannesen","year":"2020","unstructured":"Johannesen CDL, Langsted A, Mortensen MB, Nordestgaard BG. Association between low density lipoprotein and all cause and cause specific mortality in denmark: prospective cohort study. BMJ. 2020;371:m4266.","journal-title":"BMJ"},{"key":"2779_CR39","unstructured":"Grundy SM, Feingold KR. In: Feingold, et al. editors. Guidelines for the management of high blood cholesterol. South Dartmouth (MA); 2000. Endotext, K.R."},{"key":"2779_CR40","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/01.CIR.86.3.1046","volume":"86","author":"D Jacobs","year":"1992","unstructured":"Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, et al. Report of the conference on low blood cholesterol: mortality associations. Circulation. 1992;86:1046\u201360.","journal-title":"Circulation"},{"key":"2779_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/036107398244300","volume":"24","author":"P Ranieri","year":"1998","unstructured":"Ranieri P, Rozzini R, Franzoni S, Barbisoni P, Trabucchi M. Serum cholesterol levels as a measure of frailty in elderly patients. Exp Aging Res. 1998;24:169\u201379.","journal-title":"Exp Aging Res"},{"key":"2779_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58020299","author":"J Vekic","year":"2022","unstructured":"Vekic J, Zeljkovic A, Cicero AFG, Janez A, Stoian AP, Sonmez A, et al. Atherosclerosis development and progression: the role of atherogenic small, dense LDL. Medicina (Kaunas). 2022. https:\/\/doi.org\/10.3390\/medicina58020299.","journal-title":"Medicina (Kaunas)"},{"key":"2779_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241993","volume":"15","author":"L Liou","year":"2020","unstructured":"Liou L, Kaptoge S. Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: a systematic review and meta-analysis. PLoS ONE. 2020;15:e0241993.","journal-title":"PLoS ONE"},{"key":"2779_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64715-9","volume":"10","author":"T Yao","year":"2020","unstructured":"Yao T, Long Q, Li J, Li G, Ding Y, Cui Q, et al. Small dense low-density lipoprotein cholesterol is strongly associated with NIHSS score and intracranial arterial calcification in acute ischemic stroke subjects. Sci Rep. 2020;10:7645.","journal-title":"Sci Rep"},{"key":"2779_CR45","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","volume":"34","author":"RC Hoogeveen","year":"2014","unstructured":"Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014;34:1069\u201377.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2779_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cca.2012.09.010","volume":"414","author":"S Hirayama","year":"2012","unstructured":"Hirayama S, Miida T. Small dense LDL: an emerging risk factor for cardiovascular disease. Clin Chim Acta. 2012;414:215\u201324.","journal-title":"Clin Chim Acta"},{"key":"2779_CR47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/MOL.0000000000000419","volume":"28","author":"J Allaire","year":"2017","unstructured":"Allaire J, Vors C, Couture P, Lamarche B. LDL particle number and size and cardiovascular risk: anything new under the sun? Curr Opin Lipidol. 2017;28:261\u20136.","journal-title":"Curr Opin Lipidol"},{"key":"2779_CR48","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Boren","year":"2020","unstructured":"Boren J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European atherosclerosis society consensus panel. Eur Heart J. 2020;41:2313\u201330.","journal-title":"Eur Heart J"},{"key":"2779_CR49","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.atherosclerosis.2016.01.012","volume":"246","author":"RW McGarrah","year":"2016","unstructured":"McGarrah RW, Craig DM, Haynes C, Dowdy ZE, Shah SH, Kraus WE. High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort. Atherosclerosis. 2016;246:229\u201335.","journal-title":"Atherosclerosis"},{"key":"2779_CR50","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","volume":"17","author":"L Camont","year":"2011","unstructured":"Camont L, Chapman MJ, Kontush A. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol Med. 2011;17:594\u2013603.","journal-title":"Trends Mol Med"},{"key":"2779_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01726-y","volume":"21","author":"Q Jin","year":"2022","unstructured":"Jin Q, Lau ESH, Luk AO, Tam CHT, Ozaki R, Lim CKP, et al. High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong diabetes biobank. Cardiovasc Diabetol. 2022;21:293.","journal-title":"Cardiovasc Diabetol"},{"key":"2779_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82861-6","volume":"11","author":"A Teis","year":"2021","unstructured":"Teis A, Cediel G, Amigo N, Julve J, Aranyo J, Andres-Cordon J, et al. Particle size and cholesterol content of circulating HDL correlate with cardiovascular death in chronic heart failure. Sci Rep. 2021;11:3141.","journal-title":"Sci Rep"},{"key":"2779_CR53","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/thoraxjnl-2018-212144","volume":"74","author":"L Harbaum","year":"2019","unstructured":"Harbaum L, Ghataorhe P, Wharton J, Jimenez B, Howard LSG, Gibbs JSR, et al. Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension. Thorax. 2019;74:380\u20139.","journal-title":"Thorax"},{"key":"2779_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072269","author":"LM Varela","year":"2020","unstructured":"Varela LM, Meseguer E, Lapergue B, Couret D, Amarenco P, Meilhac O. Changes in high-density lipoproteins related to outcomes in patients with acute stroke. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9072269.","journal-title":"J Clin Med"},{"key":"2779_CR55","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1111\/dom.15224","volume":"25","author":"R Li","year":"2023","unstructured":"Li R, Chen JX, Lu Q, Geng TT, Xia PF, Wang Y, et al. Associations of lipoprotein subclasses with risk of all-cause and cardiovascular disease mortality in individuals with type 2 diabetes: a prospective cohort study. Diabetes Obes Metab. 2023;25:3259\u201367.","journal-title":"Diabetes Obes Metab"},{"key":"2779_CR56","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2174\/15701611113119990125","volume":"12","author":"PP Toth","year":"2014","unstructured":"Toth PP. Insulin resistance, small LDL particles, and risk for atherosclerotic disease. Curr Vasc Pharmacol. 2014;12:653\u20137.","journal-title":"Curr Vasc Pharmacol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02779-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02779-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02779-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:03:59Z","timestamp":1763136239000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02779-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2779"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02779-0","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual participants included in SHIP-START and SHIP-TREND. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The institutional review board of the University Greifswald approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"363"}}